功能性消化不良与肠易激综合征局部及全身免疫激活的证据:一项系统综述
该系统综述检索7个文献数据库,纳入51篇报告免疫特征不一致的论文,汇总功能性消化不良(FD)和肠易激综合征(IBS)中局部及全身免疫激活的证据,发现FD十二指肠嗜酸性粒细胞增多、IBS结肠肥大细胞增多及循环α4+β7+肠道归巢T细胞增加等改变,但患者亚型分型不佳使研究受限。
要点
- FD和IBS患者存在淋巴细胞群变化及局部嗜酸性粒细胞或肥大细胞增多。
- 循环α4+β7+肠道归巢T细胞增加可能与FD和IBS的病理生理相关。
- Th17反应在FGIDs中可能起作用为间接证据,Th2表型证据有限。
核心结论
- FD和IBS中肠道归巢T淋巴细胞比例的改变提示黏膜稳态丧失可能驱动FD和IBS的症状。
- 有间接证据表明Th17反应可能在FGIDs中起作用,但FD和IBS中Th2免疫表型的证据有限。
- 尽管免疫参与明显,仍需大型、特征明确的患者队列来阐明驱动FGIDs发生的免疫机制。
研究设计与样本
- 系统综述,检索7个文献数据库,关键词包括功能性胃肠病、功能性消化不良、非溃疡性消化不良、特发性消化不良、肠易激综合征及免疫相关词。
- 共51篇报告免疫特征不一致的论文符合本综述的入选标准。
主要发现
- IBS和FD中报告了B淋巴细胞和T淋巴细胞数量及活化状态等淋巴细胞群的变化。
- FD中报告了十二指肠嗜酸性粒细胞增多,IBS中报告了结肠肥大细胞增多。
- 循环α4+β7+肠道归巢T细胞的增加似乎与FD和IBS两者的病理生理相关。
- 该领域研究因患者亚组分型不佳及FD和IBS所涉免疫活动微妙而复杂化。
局限性
- 该领域研究因患者亚组分型不佳而复杂化。
- FD和IBS所涉免疫活动具有微妙性,使研究复杂化。
- 需大型、特征明确的患者队列来阐明驱动FGIDs发生的免疫机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subtle histopathologic features such as eosinophilia and increased mast cells have been observed in functional gastrointestinal disorders (FGIDs), including functional dyspepsia (FD) and the irritable bowel syndrome (IBS). The mechanisms that drive recruitment of these cells to the gastrointestinal tract remain unexplained, largely due to the heterogeneity in phenotypes among patients diagnosed with such conditions. We aimed to systematically review the literature and collate the evidence for immune activation in FD and IBS, and where possible, detail the nature of activation. METHODS: Seven literature databases were searched using the keywords: 'functional gastrointestinal disorder', FGID, 'functional dyspepsia', 'non-ulcer dyspepsia', 'idiopathic dyspepsia', 'irritable bowel syndrome', IBS and 'immun*'. RESULTS: Fifty-one papers reporting discordant immune features met the selection criteria for this review. Changes in lymphocyte populations, including B and T lymphocyte numbers and activation status were reported in IBS and FD, in conjunction with duodenal eosinophilia in FD and increased colonic mast cells in IBS. Increases in circulating α4+β7+ gut-homing T cells appear to be linked to the pathophysiology of both FD and IBS. Studies in the area are complicated by poor phenotyping of patients into subgroups and the subtle nature of the immune activity involved in FD and IBS. CONCLUSIONS: Alterations in proportions of gut-homing T lymphocytes in both FD and IBS indicate that a loss of mucosal homeostasis may drive the symptoms of FD and IBS. There is indirect evidence that Th17 responses may play a role in FGIDs, however the evidence for a Th2 immune phenotype in FD and IBS is limited. Although immune involvement is evident, large, well-characterised patient cohorts are required to elucidate the immune mechanisms driving the development of FGIDs.
引用
- Burns G, Carroll G, Mathe A, et al. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol. 2019. PMID: 30839392. doi:10.1038/s41395-018-0377-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。